Abbreviated Company Accounts - IDAMENEO (UK) LIMITED

Abbreviated Company Accounts - IDAMENEO (UK) LIMITED


Registered Number 00639379

IDAMENEO (UK) LIMITED

Abbreviated Accounts

30 June 2015

IDAMENEO (UK) LIMITED Registered Number 00639379

Abbreviated Balance Sheet as at 30 June 2015

Notes 2015 2014
£ £
Current assets
Debtors 2 159,210 159,210
159,210 159,210
Creditors: amounts falling due within one year (958) (958)
Net current assets (liabilities) 158,252 158,252
Total assets less current liabilities 158,252 158,252
Total net assets (liabilities) 158,252 158,252
Capital and reserves
Called up share capital 3 80,800 80,800
Share premium account 79,200 79,200
Profit and loss account (1,748) (1,748)
Shareholders' funds 158,252 158,252
  • For the year ending 30 June 2015 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 17 June 2016

And signed on their behalf by:
Malcolm Ashcroft, Director

IDAMENEO (UK) LIMITED Registered Number 00639379

Notes to the Abbreviated Accounts for the period ended 30 June 2015

1Accounting Policies

Basis of measurement and preparation of accounts
The financial statement have been prepared under the historic cost convention and in accordance with applicable accounting standards. The parent company, Idameneo (No.789) Limited (formerly Symbion Health Limited, incorporated in Australia, has given an undertaking to support the Company over the next twelve months and for the foreseeable future.

Other accounting policies
Cash flow statement

Under FRS 1 the Company is exempt from the requirement to prepare a cash flow statement on the grounds of its size.

Taxation

The charge for taxation is based on the result for the year and takes into account taxation deferred because of timing differences between the treatment of certain items for taxation and accounting purposes,

Deferred tax is recognised, without discounting, in respect of all timing differences between the treatment of certain items for taxation and accounting purposes which have arisen but not reversed by the balance sheet date, except as otherwise required by FRS 19.

Related party transactions

The company has taken advantage of the exemptions under FRS 8 'Related Party Disclosures' not to disclose transactions with investee group companies as the financial statements for the ultimate parent undertaking, which controls 100% of the voting rights of the company, are publicly available

Ultimate parent and controlling company

The company is a wholly owned subsidiary of Symbion International BY, a company incorporated in the Netherlands.

The smallest and largest group in which the results of the company are consolidated is that headed by Primary Health Care Limited, a company incorporated in Australia.

A copy of Primary Health Care Limited's financial statements can be obtained from the Registered Office at Level 6, 203 Pacific Highway, St Leonards, NSW, Australia, 2065.

2Debtors

Amounts due from group undertakings is £159,210 (2014: £159,210)

3Called Up Share Capital
Allotted, called up and fully paid:
2015
£
2014
£
80,800 Ordinary shares of £1 each 80,800 80,800